Metabolic Factors that Contribute to Lupus Pathogenesis.
暂无分享,去创建一个
[1] A. Lazarus,et al. Targeting FcγRs to treat antibody-dependent autoimmunity. , 2016, Autoimmunity reviews.
[2] Liping Yang,et al. Serum metabolomic profiling in patients with systemic lupus erythematosus by GC/MS , 2016, Modern rheumatology.
[3] V. Pascual,et al. Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus , 2016, The Journal of experimental medicine.
[4] R. Evans,et al. ERRγ Is Required for the Metabolic Maturation of Therapeutically Functional Glucose-Responsive β Cells. , 2016, Cell metabolism.
[5] Y. Shoenfeld,et al. Recent advances and current state of immunotherapy in systemic lupus erythematosus , 2016, Expert opinion on biological therapy.
[6] A. Margolles,et al. Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients , 2016, Scientific Reports.
[7] Andreas Radbruch,et al. Plasma cells as an innovative target in autoimmune disease with renal manifestations , 2016, Nature Reviews Nephrology.
[8] Yun-Cai Liu,et al. T follicular helper cells, T follicular regulatory cells and autoimmunity. , 2016, International immunology.
[9] Zu-Cheng Yang,et al. Hypoxia-Inducible Factor-1α and Autoimmune Lupus, Arthritis , 2016, Inflammation.
[10] Greg M. Delgoffe,et al. Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8 T cell differentiation , 2016, Nature Immunology.
[11] N. Shen,et al. Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools , 2016, Mediators of inflammation.
[12] L. Tian,et al. Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis , 2016, Science Translational Medicine.
[13] D. Green,et al. Metabolic Maintenance of Cell Asymmetry following Division in Activated T Lymphocytes , 2016, Nature.
[14] A. Davidson. What is damaging the kidney in lupus nephritis? , 2016, Nature Reviews Rheumatology.
[15] A. Perl. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases , 2016, Nature Reviews Rheumatology.
[16] B. Tirosh,et al. Metabolic Control of Plasma Cell Differentiation- What We Know and What We Don't Know , 2016, Journal of Clinical Immunology.
[17] Li Wu,et al. Phenotypic and functional alterations of pDCs in lupus-prone mice , 2016, Scientific Reports.
[18] David K. Finlay,et al. Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells , 2016, The Journal of Immunology.
[19] D. Pisetsky. Anti-DNA antibodies — quintessential biomarkers of SLE , 2016, Nature Reviews Rheumatology.
[20] H. Ueno,et al. T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis , 2016, European journal of immunology.
[21] J. Harley,et al. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification , 2016, Annals of the rheumatic diseases.
[22] D. Teachey,et al. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. , 2016, Blood.
[23] E. Pearce,et al. Immunometabolism governs dendritic cell and macrophage function , 2016, The Journal of experimental medicine.
[24] B. Croker,et al. Glucose Oxidation Is Critical for CD4+ T Cell Activation in a Mouse Model of Systemic Lupus Erythematosus , 2016, The Journal of Immunology.
[25] S. Tay,et al. The Immune-Metabolic Basis of Effector Memory CD4+ T Cell Function under Hypoxic Conditions , 2016, The Journal of Immunology.
[26] J. Buyon,et al. Endosomal Toll‐like receptors in clinically overt and silent autoimmunity , 2016, Immunological reviews.
[27] B. Diamond,et al. SLE‐associated risk factors affect DC function , 2015, Immunological reviews.
[28] L. Andrade,et al. The effects of freeze/thawing on the function and phenotype of CD4(+) lymphocyte subsets in normal individuals and patients with systemic lupus erythematosus. , 2015, Cryobiology.
[29] L. Morel,et al. Contribution of B‐1a cells to systemic lupus erythematosus in the NZM2410 mouse model , 2015, Annals of the New York Academy of Sciences.
[30] A. Kalergis,et al. Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus , 2015, Immunology.
[31] F. Pan,et al. Metabolic regulation of T cell differentiation and function. , 2015, Molecular immunology.
[32] S. Muller,et al. Autophagy is dispensable for B-cell development but essential for humoral autoimmune responses , 2015, Cell Death and Differentiation.
[33] T. Niewold,et al. Immunogenetics of systemic lupus erythematosus: A comprehensive review. , 2015, Journal of autoimmunity.
[34] Caitlyn E. Bowman,et al. Preventing Allograft Rejection by Targeting Immune Metabolism. , 2015, Cell reports.
[35] Michael A. Smith,et al. Self-reactive IgE exacerbates interferon responses associated with autoimmunity , 2015, Nature Immunology.
[36] John P. Ray,et al. The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells. , 2015, Immunity.
[37] Russell G. Jones,et al. Attenuation of AMPK signaling by ROQUIN promotes T follicular helper cell formation , 2015, eLife.
[38] W. Junger,et al. mTOR and differential activation of mitochondria orchestrate neutrophil chemotaxis , 2015, The Journal of cell biology.
[39] Andreas Radbruch,et al. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus , 2015, Annals of the rheumatic diseases.
[40] M. Buck,et al. T cell metabolism drives immunity , 2015, The Journal of experimental medicine.
[41] Y. Zou,et al. Defects in Germinal Center Selection in SLE , 2015, Front. Immunol..
[42] H. Ueno,et al. OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response. , 2015, Immunity.
[43] Ji-Min Kim,et al. A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus , 2015, International journal of molecular sciences.
[44] Vaishali R. Moulton,et al. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. , 2015, The Journal of clinical investigation.
[45] F. Gage,et al. Dependence of hippocampal function on ERRγ-regulated mitochondrial metabolism. , 2015, Cell metabolism.
[46] R. Talaat,et al. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. , 2015, Cytokine.
[47] E. Bonfá,et al. Circulating Follicular Helper–Like T Cells in Systemic Lupus Erythematosus: Association With Disease Activity , 2015, Arthritis & rheumatology.
[48] Laura M. Davison,et al. Sialic Acid–Binding Immunoglobulin‐Type Lectin H–Positive Plasmacytoid Dendritic Cells Drive Spontaneous Lupus‐like Disease Development in B6.Nba2 Mice , 2015, Arthritis & rheumatology.
[49] B. Diamond,et al. Therapeutics to block autoantibody initiation and propagation in systemic lupus erythematosus and rheumatoid arthritis , 2015, Science Translational Medicine.
[50] G. Tsokos,et al. T cells as a therapeutic target in SLE , 2015, Lupus.
[51] M. Shlomchik,et al. Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus. , 2015, Immunity.
[52] L. O’Neill. A broken krebs cycle in macrophages. , 2015, Immunity.
[53] K. Tung,et al. BAFF Regulates Follicular Helper T Cells and Affects Their Accumulation and Interferon‐γ Production in Autoimmunity , 2015, Arthritis & rheumatology.
[54] A. Cuervo,et al. Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide , 2015, Autophagy.
[55] Mark M. Davis,et al. Tetramers reveal IL-17–secreting CD4+ T cells that are specific for U1-70 in lupus and mixed connective tissue disease , 2015, Proceedings of the National Academy of Sciences.
[56] T. Preiss,et al. Roquin binds microRNA-146a and Argonaute2 to regulate microRNA homeostasis , 2015, Nature Communications.
[57] E. Matteson,et al. T-cell metabolism in autoimmune disease , 2015, Arthritis Research & Therapy.
[58] B. Croker,et al. Normalization of CD4+ T cell metabolism reverses lupus , 2015, Science Translational Medicine.
[59] Erika L. Pearce,et al. Targeting T cell metabolism for therapy. , 2015, Trends in immunology.
[60] P. Toogood,et al. Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists. , 2015, Nature chemical biology.
[61] U. Panzer,et al. Function of the Th17/Interleukin‐17A Immune Response in Murine Lupus Nephritis , 2015, Arthritis & rheumatology.
[62] H. Ueno,et al. Pathophysiology of T follicular helper cells in humans and mice , 2015, Nature Immunology.
[63] B. Everts,et al. Dendritic cell metabolism , 2014, Nature Reviews Immunology.
[64] L. Morel,et al. Contributions of B cells to lupus pathogenesis. , 2014, Molecular immunology.
[65] David K. Finlay,et al. mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function , 2014, The Journal of Immunology.
[66] L. Boros,et al. Anaplerotic Metabolism of Alloreactive T Cells Provides a Metabolic Approach To Treat Graft-Versus-Host Disease , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[67] Christophe Pellefigues,et al. Immunoglobulin E plays an immunoregulatory role in lupus , 2014, The Journal of experimental medicine.
[68] M. Berger,et al. mTOR Activation Promotes Plasma Cell Differentiation and Bypasses XBP-1 for Immunoglobulin Secretion , 2014, Molecular and Cellular Biology.
[69] S. Crotty. T follicular helper cell differentiation, function, and roles in disease. , 2014, Immunity.
[70] Nataliya Gorinski,et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells , 2014, Nature Medicine.
[71] E. Unanue,et al. Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model , 2014, The Journal of experimental medicine.
[72] V. D’Agati,et al. Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus , 2014, The Journal of experimental medicine.
[73] L. Ma,et al. Increased Interleukin 21 and Follicular Helper T-like Cells and Reduced Interleukin 10+ B cells in Patients with New-onset Systemic Lupus Erythematosus , 2014, The Journal of Rheumatology.
[74] G. Tsokos,et al. The role of T cells in systemic lupus erythematosus: an update , 2014, Current opinion in rheumatology.
[75] Q. Ma,et al. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells. , 2014, Immunology letters.
[76] H. Hsu,et al. Dysregulated Cytokine Production by Dendritic Cells Modulates B Cell Responses in the NZM2410 Mouse Model of Lupus , 2014, PloS one.
[77] L. O’Neill,et al. Metabolic Reprograming in Macrophage Polarization , 2014, Front. Immunol..
[78] A. Kribben,et al. Increased percentages of PD-1 on CD4+ T cells is associated with higher INF-γ production and altered IL-17 production in patients with systemic lupus erythematosus , 2014, Scandinavian journal of rheumatology.
[79] M. Birnbaum,et al. Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. , 2014, Immunity.
[80] F. Shi,et al. IL-17 Promotes Murine Lupus , 2014, The Journal of Immunology.
[81] K. Tung,et al. Neutrophils Contribute to Excess Serum BAFF Levels and Promote CD4+ T Cell and B Cell Responses in Lupus-Prone Mice , 2014, PloS one.
[82] J. Rathmell,et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. , 2014, Cell metabolism.
[83] A. Perl,et al. Metabolic control of the epigenome in systemic Lupus erythematosus , 2014, Autoimmunity.
[84] T. Rauen,et al. CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance. , 2014, The Journal of clinical investigation.
[85] L. O’Neill,et al. Succinate: a metabolic signal in inflammation. , 2014, Trends in cell biology.
[86] A. Perl,et al. Mechanistic Target of Rapamycin Complex 1 Expands Th17 and IL-4+ CD4−CD8− Double-Negative T Cells and Contracts Regulatory T Cells in Systemic Lupus Erythematosus , 2014, The Journal of Immunology.
[87] D. Green,et al. Metabolic Reprogramming Is Required for Antibody Production That Is Suppressed in Anergic but Exaggerated in Chronically BAFF-Exposed B Cells , 2014, The Journal of Immunology.
[88] M. Giger,et al. Cell Distance Mapping Identifies Functional T Follicular Helper Cells in Inflamed Human Renal Tissue , 2014, Science Translational Medicine.
[89] B. Everts,et al. Metabolic Control of Dendritic Cell Activation and Function: Recent Advances and Clinical Implications , 2014, Front. Immunol..
[90] D. Isenberg,et al. Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients. , 2014, The Journal of clinical investigation.
[91] Tomomi Sato,et al. Deficient Leptin Signaling Ameliorates Systemic Lupus Erythematosus Lesions in MRL/Mp-Faslpr Mice , 2014, The Journal of Immunology.
[92] Maria R. Gumina,et al. Glucose-dependent de Novo Lipogenesis in B Lymphocytes , 2014, The Journal of Biological Chemistry.
[93] T. Vyse,et al. Autophagy is activated in systemic lupus erythematosus and required for plasmablast development , 2014, Annals of the rheumatic diseases.
[94] Hong Wang,et al. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases , 2014, Biomarker Research.
[95] C. Mackay,et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. , 2013, Immunity.
[96] A. Korganow,et al. Circulating TFH Subset Distribution Is Strongly Affected in Lupus Patients with an Active Disease , 2013, PloS one.
[97] K. Morris,et al. Interferon-γ and systemic autoimmunity. , 2013, Discovery medicine.
[98] K. Druey,et al. IL-17RA Is Essential for Optimal Localization of Follicular Th Cells in the Germinal Center Light Zone To Promote Autoantibody-Producing B Cells , 2013, The Journal of Immunology.
[99] A. Blom,et al. Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus , 2013, Arthritis Research & Therapy.
[100] G. Tsokos,et al. Gene-function studies in systemic lupus erythematosus , 2013, Nature Reviews Rheumatology.
[101] Peter Vogel,et al. mTORC1 couples immune signals and metabolic programming to establish Treg cell function , 2013, Nature.
[102] G. Tsokos,et al. Treatment with Anti-Interleukin 23 Antibody Ameliorates Disease in Lupus-Prone Mice , 2013, BioMed research international.
[103] Jing Yuan,et al. A Novel Epitope from CD22 Regulates Th1 and Th17 Cell Function in Systemic Lupus Erythematosus , 2013, PloS one.
[104] G. Tsokos,et al. New therapeutics in systemic lupus erythematosus , 2013, Current opinion in rheumatology.
[105] Liang Zheng,et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.
[106] J. Rathmell,et al. Metabolic regulation of T lymphocytes. , 2013, Annual review of immunology.
[107] M. Shlomchik,et al. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. , 2013, Immunity.
[108] B. Beutler,et al. Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus , 2013, Proceedings of the National Academy of Sciences.
[109] C. Carmona-Rivera,et al. Neutrophil Extracellular Trap–Associated Protein Activation of the NLRP3 Inflammasome Is Enhanced in Lupus Macrophages , 2013, The Journal of Immunology.
[110] S. Casola,et al. Plasma cells require autophagy for sustainable immunoglobulin production , 2013, Nature Immunology.
[111] Lingyun Sun,et al. Inhibition of Aberrant Circulating Tfh Cell Proportions by Corticosteroids in Patients with Systemic Lupus Erythematosus , 2012, PloS one.
[112] J. Gómez-Reino,et al. Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial , 2012, Annals of the rheumatic diseases.
[113] T. Chiles,et al. Protein kinase Cβ is critical for the metabolic switch to glycolysis following B-cell antigen receptor engagement. , 2012, The Biochemical journal.
[114] M. Shlomchik,et al. NADPH Oxidase Inhibits the Pathogenesis of Systemic Lupus Erythematosus , 2012, Science Translational Medicine.
[115] N. Shen,et al. Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. , 2012, Autoimmunity reviews.
[116] G. Tsokos,et al. Calcium/Calmodulin-Dependent Protein Kinase IV Suppresses IL-2 Production and Regulatory T Cell Activity in Lupus , 2012, The Journal of Immunology.
[117] K. Elkon,et al. Type I IFN system in the development and manifestations of SLE , 2012, Current opinion in rheumatology.
[118] K. Yarasheski,et al. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. , 2012, Blood.
[119] H. Baker,et al. Murine Lupus Susceptibility Locus Sle1c2 Mediates CD4+ T Cell Activation and Maps to Estrogen-Related Receptor γ , 2012, The Journal of Immunology.
[120] J. Craft. Follicular helper T cells in immunity and systemic autoimmunity , 2012, Nature Reviews Rheumatology.
[121] L. Morel,et al. Aberrant Macrophages Mediate Defective Kidney Repair That Triggers Nephritis in Lupus-Susceptible Mice , 2012, The Journal of Immunology.
[122] A. Blom,et al. Neutrophil Extracellular Traps That Are Not Degraded in Systemic Lupus Erythematosus Activate Complement Exacerbating the Disease , 2012, The Journal of Immunology.
[123] M. Horton,et al. Regulation of immune responses by mTOR. , 2012, Annual review of immunology.
[124] M. Sanak,et al. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus. , 2012, Folia histochemica et cytobiologica.
[125] H. Baker,et al. Pre-B Cell Leukemia Homeobox 1 Is Associated with Lupus Susceptibility in Mice and Humans , 2012, The Journal of Immunology.
[126] D. Green,et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.
[127] E. Pamer,et al. Monocyte recruitment during infection and inflammation , 2011, Nature Reviews Immunology.
[128] T. Rauen,et al. cAMP-responsive Element Modulator (CREM)α Protein Induces Interleukin 17A Expression and Mediates Epigenetic Alterations at the Interleukin-17A Gene Locus in Patients with Systemic Lupus Erythematosus* , 2011, The Journal of Biological Chemistry.
[129] Mariana J. Kaplan,et al. Neutrophils in the pathogenesis and manifestations of SLE , 2011, Nature Reviews Rheumatology.
[130] X. Bosch. Systemic lupus erythematosus and the neutrophil. , 2011, The New England journal of medicine.
[131] T. Mak,et al. IRF4 deficiency abrogates lupus nephritis despite enhancing systemic cytokine production. , 2011, Journal of the American Society of Nephrology : JASN.
[132] A. Tyndall,et al. [Stem cell treatment of autoimmune disease]. , 2011, Deutsche medizinische Wochenschrift.
[133] D. Green,et al. HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.
[134] V. Giguère,et al. Estrogen related receptors (ERRs): a new dawn in transcriptional control of mitochondrial gene networks. , 2011, Mitochondrion.
[135] Matthias Kretzler,et al. Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus , 2011, The Journal of Immunology.
[136] L. Morel,et al. Defective response of CD4+ T cells to retinoic acid and TGFβ in systemic lupus erythematosus , 2011, Arthritis research & therapy.
[137] J. Rathmell,et al. Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.
[138] Tomoki Ito,et al. Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus , 2011, Science Translational Medicine.
[139] J. Connolly,et al. Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus , 2011, Science Translational Medicine.
[140] V. Pascual,et al. Interferon‐α induces unabated production of short‐lived plasma cells in pre‐autoimmune lupus‐prone (NZB×NZW)F1 mice but not in BALB/c mice , 2011, European journal of immunology.
[141] Andreas Radbruch,et al. Long-lived autoreactive plasma cells drive persistent autoimmune inflammation , 2011, Nature Reviews Rheumatology.
[142] Guoliang Cui,et al. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. , 2011, The Journal of clinical investigation.
[143] H. Ueno,et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. , 2011, Immunity.
[144] Thomas B. Sundberg,et al. Manipulating the Bioenergetics of Alloreactive T Cells Causes Their Selective Apoptosis and Arrests Graft-Versus-Host Disease , 2011, Science Translational Medicine.
[145] M. Shlomchik,et al. Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. , 2010, Immunity.
[146] J. O’Shea,et al. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. , 2010, Cytokine & growth factor reviews.
[147] W. Reeves,et al. Monocyte and Macrophage Abnormalities in Systemic Lupus Erythematosus , 2010, Archivum Immunologiae et Therapiae Experimentalis.
[148] A. Opipari,et al. Characterization of the metabolic phenotype of chronically activated lymphocytes , 2010, Lupus.
[149] P. Sfikakis,et al. The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. , 2010, Seminars in arthritis and rheumatism.
[150] Abdul Hakkim,et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis , 2010, Proceedings of the National Academy of Sciences.
[151] V. Kuchroo,et al. Cutting Edge: IL-23 Receptor Deficiency Prevents the Development of Lupus Nephritis in C57BL/6–lpr/lpr Mice , 2010, The Journal of Immunology.
[152] Yunyu Zhang,et al. Estrogen-related Receptor γ Is a Key Regulator of Muscle Mitochondrial Activity and Oxidative Capacity , 2010, The Journal of Biological Chemistry.
[153] E. Campbell,et al. Metabolic Shifts in Immunity and Inflammation , 2010, The Journal of Immunology.
[154] W. Mccune,et al. A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs , 2010, The Journal of Immunology.
[155] C. Hedrick,et al. ATP-Binding Cassette Transporter G1 Negatively Regulates Thymocyte and Peripheral Lymphocyte Proliferation , 2009, The Journal of Immunology.
[156] D. Rajpal,et al. ERRγ Regulates Cardiac, Gastric, and Renal Potassium Homeostasis. , 2009, Endocrine reviews.
[157] E. Silverman,et al. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. , 2009, Arthritis and rheumatism.
[158] V. Nizet,et al. Interdependence of hypoxic and innate immune responses , 2009, Nature Reviews Immunology.
[159] G. Tsokos,et al. The Role of IL-23/IL-17 Axis in Lupus Nephritis1 , 2009, The Journal of Immunology.
[160] Xinrui Li,et al. Fcγ receptors: structure, function and role as genetic risk factors in SLE , 2009, Genes and Immunity.
[161] Ming Li,et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. , 2009, Arthritis and rheumatism.
[162] M. Cook,et al. Follicular helper T cells are required for systemic autoimmunity , 2009, The Journal of experimental medicine.
[163] W. Leonard,et al. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice , 2009, Proceedings of the National Academy of Sciences.
[164] D. Metz,et al. B7RP-1 Blockade Ameliorates Autoimmunity through Regulation of Follicular Helper T Cells , 2009, The Journal of Immunology.
[165] M. Oukka,et al. Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys1 , 2008, The Journal of Immunology.
[166] G. Tsokos,et al. Cholera Toxin B Accelerates Disease Progression in Lupus-Prone Mice by Promoting Lipid Raft Aggregation1 , 2008, The Journal of Immunology.
[167] S. Tam,et al. Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice. , 2008, Nephrology, Dialysis and Transplantation.
[168] J. Smolen,et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). , 2008, International immunology.
[169] John E. Connolly,et al. Systemic IFN‐α drives kidney nephritis in B6.Sle123 mice , 2008, European journal of immunology.
[170] P. Mease. B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application. , 2008, The Journal of rheumatology.
[171] Biyan Duan,et al. Direct B cell stimulation by dendritic cells in a mouse model of lupus. , 2008, Arthritis and rheumatism.
[172] T. Kuijpers,et al. Mitochondrial Membrane Potential in Human Neutrophils Is Maintained by Complex III Activity in the Absence of Supercomplex Organisation , 2008, PloS one.
[173] M. McGeachy,et al. Review Th17 Cell Differentiation: the Long and Winding Road , 2022 .
[174] J. Rathmell,et al. Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways1 , 2008, The Journal of Immunology.
[175] Robert W. Williams,et al. Interleukin 17–producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice , 2008, Nature Immunology.
[176] V. Giguère. Transcriptional control of energy homeostasis by the estrogen-related receptors. , 2008, Endocrine reviews.
[177] B. Croker,et al. Murine Lupus Susceptibility Locus Sle1a Controls Regulatory T Cell Number and Function through Multiple Mechanisms1 , 2007, The Journal of Immunology.
[178] Y. Cho,et al. Five‐aminoimidazole‐4‐carboxamide‐1‐β‐4‐ribofuranoside attenuates poly (I:C)‐induced airway inflammation in a murine model of asthma , 2007, Clinical and Experimental Allergy.
[179] Maria R. Gumina,et al. Cutting Edge: IL-4-Mediated Protection of Primary B Lymphocytes from Apoptosis via Stat6-Dependent Regulation of Glycolytic Metabolism1 , 2007, The Journal of Immunology.
[180] J. Alcocer-Varela,et al. The role myeloid dendritic cells play in the pathogenesis of systemic lupus erythematosus. , 2007, Autoimmunity reviews.
[181] C. Scavone,et al. Neutrophil function and metabolism in individuals with diabetes mellitus. , 2007, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[182] C. Shelley,et al. Identification of Purα as a New Hypoxia Response Factor Responsible for Coordinated Induction of the β2 Integrin Family1 , 2007, The Journal of Immunology.
[183] R. Naviaux,et al. ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. , 2007, Cell metabolism.
[184] J. Gottenberg,et al. Dendritic cells and interferon-mediated autoimmunity. , 2007, Biochimie.
[185] L. Morel,et al. IL-6 Produced by Dendritic Cells from Lupus-Prone Mice Inhibits CD4+CD25+ T Cell Regulatory Functions1 , 2007, The Journal of Immunology.
[186] V. Pascual,et al. Systemic lupus erythematosus: all roads lead to type I interferons. , 2006, Current opinion in immunology.
[187] D. Isenberg,et al. Atorvastatin Restores Lck Expression and Lipid Raft-Associated Signaling in T Cells from Patients with Systemic Lupus Erythematosus1 , 2006, The Journal of Immunology.
[188] W. Mccune,et al. Aberrant Phenotype and Function of Myeloid Dendritic Cells in Systemic Lupus Erythematosus1 , 2006, The Journal of Immunology.
[189] A. Perl,et al. Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. , 2006, Arthritis and rheumatism.
[190] V. Pascual,et al. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. , 2006, Immunity.
[191] D. Witte,et al. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. , 2006, Arthritis and rheumatism.
[192] D. Greaves,et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. , 2006, Cell metabolism.
[193] T. Chiles,et al. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. , 2006, Blood.
[194] Simon B. Brown,et al. Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. , 2006, Arthritis and rheumatism.
[195] C. Gutiérrez,et al. Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids , 2006, Annals of the rheumatic diseases.
[196] L. Pasquier,et al. Orphanet Journal of Rare Diseases , 2006 .
[197] R. Curi,et al. Diabetes causes marked changes in function and metabolism of rat neutrophils. , 2006, The Journal of endocrinology.
[198] V. Nizet,et al. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. , 2005, The Journal of clinical investigation.
[199] R. Copley,et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity , 2005, Nature.
[200] C. Mawrin,et al. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. , 2005, The Journal of clinical investigation.
[201] C. Print,et al. Hypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity , 2005, The Journal of experimental medicine.
[202] C. Shelley,et al. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[203] G. Nagy,et al. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. , 2004, Trends in immunology.
[204] M. Nambiar,et al. Alterations in Lipid Raft Composition and Dynamics Contribute to Abnormal T Cell Responses in Systemic Lupus Erythematosus12 , 2004, The Journal of Immunology.
[205] A. Zychlinsky,et al. Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.
[206] S. Srinivasula,et al. Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis , 2004, Cell Death and Differentiation.
[207] C. Lau,et al. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. , 2003, Arthritis and rheumatism.
[208] Virginia Pascual,et al. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.
[209] A. Perl,et al. Metabolic switches of T-cell activation and apoptosis. , 2002, Antioxidants & redox signaling.
[210] C. Thompson,et al. The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.
[211] A. Tarakhovsky,et al. Protein kinase Cδ controls self-antigen-induced B-cell tolerance , 2002, Nature.
[212] Virginia Pascual,et al. Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus , 2001, Science.
[213] K. Blenman,et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[214] R. Voll,et al. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. , 1998, Arthritis and rheumatism.
[215] B. Ryffel,et al. IFN-γ Receptor Deletion Prevents Autoantibody Production and Glomerulonephritis in Lupus-Prone (NZB × NZW)F1 Mice , 1998, The Journal of Immunology.
[216] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[217] P. Allavena,et al. Anti‐tumor and immunomodulatory activity of intraperitoneal IFN‐γ in ovarian carcinoma patients with minimal residual tumor after chemotherapy , 1992, International journal of cancer.
[218] Jeppe Sturis,et al. Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.
[219] P. Allavena,et al. Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells. , 1990, Cancer research.
[220] S. Abramson,et al. Neutrophil aggregation induced by sera from patients with active systemic lupus erythematosus. , 1983, Arthritis and rheumatism.
[221] T. Herlin,et al. Energy metabolism of human neutrophils during phagocytosis. , 1982, The Journal of clinical investigation.
[222] A. Steinberg,et al. Hematologic aspects of systemic lupus erythematosus. Current concepts. , 1977, Annals of internal medicine.
[223] Kritika Ramani,et al. Interleukin 17 signaling drives Type I Interferon induced proliferative crescentic glomerulonephritis in lupus-prone mice. , 2016, Clinical immunology.
[224] J. Moslehi,et al. Roles of Interferon-g and Interleukin-4 in Murine Lupus , 2013 .
[225] S. Ganeb,et al. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus. , 2012, The Egyptian journal of immunology.
[226] C. Loddenkemper,et al. Impaired immune functions of monocytes and macrophages in Whipple's disease. , 2010, Gastroenterology.
[227] S. Tangye,et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. , 2010, Arthritis and rheumatism.
[228] David R Fernandez,et al. Metabolic control of T cell activation and death in SLE. , 2009, Autoimmunity reviews.
[229] M. Kaplan,et al. Dendritic cells and the immunopathogenesis of systemic lupus erythematosus , 2007, Immunologic research.
[230] A. Llera,et al. [Neutrophil-dependent inflammatory reactions in systemic lupus erythematosus]. , 1989, Medicina.